a2 Milk Co. Secures Early Regulatory Approvals to Progress China-Label Formula

MT Newswires Live
2025/11/24

a2 Milk Co. (NZE:ATM, ASX:A2M) secured early approvals from New Zealand's Ministry for Primary Industries and China's General Administration of Customs to transition two infant milk formula products acquired with the a2 Pokeno facility to the company-branded products, according to a Monday filing with the Australian and New Zealand bourses.

The final step involves submitting for approval from the State Administration for Market Regulation, scheduled for December, with the review process anticipated to take around six months, per the filing.

The company remains on track to launch the new products in the late first half of 2027, the filing added.

The company's New Zealand shares shed about 2% in recent Monday trade.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10